Psychemedics - 13 Year Stock Price History | PMD
Historical daily share price chart and data for Psychemedics since 2011 adjusted for splits and dividends. The latest closing stock price for Psychemedics as of December 12, 2024 is 2.67.
- The all-time high Psychemedics stock closing price was 22.06 on July 11, 2017.
- The Psychemedics 52-week high stock price is 0.00, which is -100% above the current share price.
- The Psychemedics 52-week low stock price is 0.00, which is 100% below the current share price.
- The average Psychemedics stock price for the last 52 weeks is 0.00.
| Psychemedics Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2024 | 2.5859 | 3.3900 | 3.7900 | 1.6400 | 2.6700 | -9.80% |
| 2023 | 4.3786 | 4.7979 | 6.2967 | 2.0600 | 2.9600 | -37.99% |
| 2022 | 6.1351 | 6.7267 | 7.1124 | 4.7687 | 4.7733 | -27.73% |
| 2021 | 6.7717 | 4.8016 | 8.2113 | 4.6241 | 6.6044 | 38.90% |
| 2020 | 5.3812 | 8.2421 | 9.7257 | 3.4281 | 4.7549 | -43.26% |
| 2019 | 10.0948 | 13.7968 | 16.7698 | 6.4703 | 8.3795 | -38.19% |
| 2018 | 16.3799 | 17.1064 | 18.6825 | 12.0883 | 13.5576 | -20.09% |
| 2017 | 16.9676 | 19.2163 | 22.0569 | 13.6087 | 16.9661 | -14.14% |
| 2016 | 13.1454 | 7.4966 | 20.1611 | 6.1624 | 19.7608 | 152.68% |
| 2015 | 10.0752 | 11.1042 | 13.1409 | 7.4434 | 7.8206 | -29.99% |
| 2014 | 10.9192 | 10.2669 | 13.2165 | 9.5238 | 11.1706 | 7.25% |
| 2013 | 8.5466 | 7.3491 | 10.4158 | 7.3491 | 10.4158 | 43.31% |
| 2012 | 6.9678 | 5.9117 | 8.3072 | 5.9117 | 7.2680 | 24.97% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.000B | $0.020B |
| Psychemedics Corporation provides testing services for the detection of abused substances through the analysis of hair samples. Their testing methods utilize a patented technology for performing immunoassays on enzymatically dissolved hair samples with confirmation testing by mass spectrometry. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.514B | 13.37 |
| Quest Diagnostics (DGX) | United States | $21.197B | 19.44 |
| Elanco Animal Health (ELAN) | United States | $11.500B | 24.35 |
| Encompass Health (EHC) | United States | $10.662B | 19.64 |
| DaVita (DVA) | United States | $10.023B | 13.82 |
| Chemed (CHE) | United States | $5.639B | 19.57 |
| Option Care Health (OPCH) | United States | $4.553B | 18.71 |
| RadNet (RDNT) | United States | $4.302B | 142.13 |
| LifeStance Health (LFST) | United States | $2.495B | 320.00 |
| Addus HomeCare (ADUS) | United States | $1.719B | 16.61 |
| Astrana Health (ASTH) | United States | $1.536B | 31.40 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.353B | 12.20 |
| U.S Physical Therapy (USPH) | United States | $1.157B | 29.19 |
| Pennant (PNTG) | United States | $1.072B | 31.31 |
| Daxor (DXR) | United States | $0.048B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.032B | 0.00 |